Form 4: PAVmed Inc. Director Debra White Acquires Restricted Stock

PAVmed Inc. reports that Director Debra White acquired 13,930 shares of common stock as restricted stock under an equity incentive plan.

Summary

• Director Debra White acquired 13,930 shares of PAVmed Inc. common stock on April 2, 2026.
• These shares were granted as restricted stock under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan.
• The restricted stock has a single vesting date of May 20, 2029, and is subject to forfeiture if the service period is not completed.
• Following this transaction, Debra White beneficially owns 21,097 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard disclosure of restricted stock acquisition by a director, with no immediate financial performance indicators or significant strategic shifts.

Positives

• Director acquisition of stock can signal confidence in the company's future prospects.
• The grant of restricted stock indicates a long-term incentive for the director.

Negatives

• The restricted stock is subject to forfeiture, indicating potential conditions for ownership.

Risks

• The restricted stock is subject to forfeiture if the requisite service period is not completed.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding future financial performance. The vesting date of the restricted stock in 2029 suggests a long-term outlook for the director's engagement.

Industry Context

StockSavvy.ai notes that Form 4 filings, such as this one from PAVmed Inc., are standard disclosures for insider transactions. The acquisition of restricted stock by a director is a common practice for aligning executive incentives with long-term company performance, particularly in the healthcare technology sector where PAVmed operates.

Corporate Governance

Stakeholder Impact

• Shareholders: The acquisition of stock by a director may be viewed positively as a sign of commitment, but the restricted nature and potential forfeiture introduce a conditional element.
• Employees: The incentive plan under which the stock was granted may be part of a broader employee compensation strategy.
• Management: The filing confirms the ongoing role and incentive structure for Director Debra White.

Next Steps

• The restricted stock will vest on May 20, 2029, provided the requisite service period is completed.
• Debra White will continue to hold her position as Director of PAVmed Inc.

Key Dates

Keywords

PAVmed Inc., PAVM, Form 4, Restricted Stock, Equity Incentive Plan, Director, Beneficial Ownership, Securities Exchange Act